Found 7 entries containing 'IBUPROFEN'.

C01EB16 Ibuprofen
G02CC01Ibuprofen
M01AE01 Ibuprofen
M01AE01 Ibuprofen
M01AE14 Dexibuprofen
M01AE51 Ibuprofen, combinations
M02AA1 Ibuprofen
Ibuprofen
!ronouncation" #E$E%bue%!&'E%fen(
C)ass" *+AID
,ra-e *ames"
Advil
% ,ab)ets 200 m.
,ra-e *ames"
Advil i!ui"#els
% Capsu)es 200 m.
,ra-e *ames"
Advil $igraine
% Capsu)es 200 m.
,ra-e *ames"
%&ildren's Advil
% ,ab)ets, c/e0ab)e 50 m.
% +uspension 100 m. per 5 m1
,ra-e *ames"
%&ildren's $otrin
% ,ab)ets, c/e0ab)e 50 m.
% +uspension 100 m. per 5 m1
,ra-e *ames"
Ibutab
% ,ab)ets 200 m.
,ra-e *ames"
Infant's $otrin
% 'ra) -rops 40 m.2m1
,ra-e *ames"
'unior (trengt& Advil
% ,ab)ets, c/e0ab)e 100 m.
,ra-e *ames"
'unior (trengt& $otrin
% ,ab)ets 100 m.
% ,ab)ets, c/e0ab)e 100 m.
,ra-e *ames"
$idol $a)i*u* (trengt& %ra*p For*ula
% ,ab)ets 200 m.
,ra-e *ames"
$otrin
% ,ab)ets 400 m.
% ,ab)ets 600 m.
% ,ab)ets 300 m.
,ra-e *ames"
$otrin IB
% ,ab)ets 200 m.
,ra-e *ames"
$otrin $igraine Pain
% ,ab)ets 200 m.
,ra-e *ames"
Pedia%are Fever
% +uspension 100 m. per 5 m1
% 'ra) -rops 40 m.2m1
,ra-e *ames"
Pediatric Advil +rops
% +uspension 100 m. per 245 m1
Apo"Ibuprofen #Cana-a(
$otrin IB E)tra (trengt& #Cana-a(
$otrin IB (uper (trengt& #Cana-a(
Novo"Profen #Cana-a(
Nu"Ibuprofen #Cana-a(
P&ar*acolog,
Feedback for Ibuprofen
As a treatment for444 A5. 6ser &atin.s 789
&/eumatoi- Art/ritis
-.
1 comments &ate it:
;ea-ac/e
-.
0 comments &ate it:
!erio- !ain
-.
0 comments &ate it:
+/o0in. / of -. con-itions % +/o0 A))444
Compare 0it/ ot/er -ru.s4
Decreases inf)ammation, pain, an- fe5er, probab)< t/rou./ in/ibition of
c<c)oox<.enase acti5it< an- prosta.)an-in s<nt/esis4
P&ar*aco0inetics
Absorption
, max is 1 to 2 /4 Bioa5ai)abi)it< is )ess t/an 30=4
Eli*ination
!)asma t > is 143 to 2 /4 45= to ?@= is e)iminate- t/rou./ t/e urine4 C) is to 5
12/4
Indications and Usage
&e)ief of si.ns an- s<mptoms of r/eumatoi- art/ritis an- osteoart/ritis, mi)- to
mo-erate pain, primar< -<smenorr/ea, re-uction of fe5er, mi.raine4
%ontraindications
,reatment of perioperati5e pain in t/e settin. of coronar< arter< b<pass .raft
sur.er<A patients 0/o /a5e experience- ast/ma, urticaria, or a))er.ic%t<pe
reactions after taBin. aspirin or ot/er *+AIDsA /<persensiti5it< to an< component
of t/e pro-uct4
+osage and Ad*inistration
R&eu*atoid Art&ritis and Osteoart&ritis
Adults
!' 00 to 300 m. times -ai)< to 4 times -ai)<, not to excee- 42 .2-a<4
$ild to $oderate Pain
Adults
!' 400 m. e5er< 4 to 6 / as nee-e-4
Pri*ar, +,s*enorr&ea
Adults
!' 400 m. e5er< 4 / as nee-e-4
Fever Reduction
%&ildren - to -1 ,r of age
@42CC #10245CD( an- )ess, recommen-e- -ose !' 5 m.2B.A more t/an @42CC
#10245CD(, recommen-e- -ose !' 10 m.2B.A max -ai)< -ose 40 m.2B.4
O2% Use 3$inor Ac&es4Pains5 +,s*enorr&ea5 Fever Reduction6
!' 200 m. e5er< 4 to 6 /4 Do not excee- 142 . in 24 /, or taBe for pain for more
t/an 10 -a<s or for fe5er for more t/an -a<s, un)ess -irecte- b< /ea)t/ care
pro5i-er4 6se sma))est effecti5e -ose4
O2% Use 3$igraine6
Adults
!' 400 m. 0it/ a .)ass of 0ater4 If s<mptoms persist or 0orsen, contact /ea)t/
care pro5i-er4 Do not excee- 400 m. in 24 / or for )on.er t/an 10 -a<s un)ess
-irecte- b< /ea)t/ care pro5i-er4
O2% Use 3%&ildren6
!' If possib)e, use 0ei./t to -oseA ot/er0ise, use a.e4 Ma< repeat -ose e5er< 6
to 3 /4 Do not use more t/an 4 times per -a<4
C/i)-ren 12 to 1? )bs or 6 to 11 mo of a.e, .i5e 50 m.4
C/i)-ren 13 to 2 )bs or 12 to 2 mo of a.e, .i5e ?5 m.4
C/i)-ren 24 to 5 )bs or 2 to <r of a.e, .i5e 100 m.4
C/i)-ren 6 to 4? )bs or 4 to 5 <r of a.e, .i5e 150 m.4
C/i)-ren 43 to 5@ )bs or 6 to 3 <r of a.e, .i5e 200 m.4
C/i)-ren 60 to ?1 )bs or @ to 10 <r of a.e, .i5e 250 m.4
C/i)-ren ?2 to @5 )bs or 11 <r of a.e, .i5e 00 m.4
(torage4(tabilit,
+tore at 63C to ??CD4
+rug Interactions
A%E in&ibitors
Anti/<pertensi5e effect of ACE in/ibitors ma< be -iminis/e-4
Aspirin
!rotein bin-in. of ibuprofen ma< be re-uce-A in a--ition, t/e risB of .astric
erosion an- b)ee-in. ma< be increase-4
Beta"bloc0ers
Anti/<pertensi5e effect ma< be -ecrease-4
+igo)in
Ibuprofen ma< increase -i.oxin serum )e5e)s4
+iuretics
Diuretic effects ma< be -ecrease-4
it&iu*
Ma< increase )it/ium )e5e)s4
$et&otre)ate
Ma< increase met/otrexate )e5e)s4
7arfarin
Ma< increase risB of .astric erosion an- b)ee-in.4
aborator, 2est Interactions
*one 0e)) -ocumente-4
Adverse Reactions
%ardiovascular
E-ema, f)ui- retention #.reater t/an 1= an- )ess t/an =(4
%N(
DiEEiness #= to @=(A /ea-ac/e, ner5ousness #.reater t/an 1= an- )ess t/an
=(4
+er*atologic
&as/ inc)u-in. macu)opapu)ar #= to @=(A pruritus #.reater t/an 1= an- )ess
t/an =(4
EEN2
,innitus #.reater t/an 1= an- )ess t/an =(4
#I
Epi.astric pain, /eartburn, nausea #= to @=(A ab-omina) cramps or pain,
ab-omina) -istress, constipation, -iarr/ea, fu))ness of GI tract #b)oatin.,
f)atu)ence(, in-i.estion, nausea an- 5omitin. #.reater t/an 1= an- )ess t/an
=(4
$etabolic"Nutritional
Decrease- appetite #.reater t/an 1= an- )ess t/an =(4
Precautions
7arnings
*+AIDs ma< cause an increase- risB of serious CF t/rombotic e5ents, MI, an- stroBe, 0/ic/ can be fata)4
,/is risB ma< increase 0it/ )en.t/ of t/erap<4 !atients 0it/ CF -isease or risB factors for CF -isease ma< be
at .reater risB4 *+AIDs cause an increase- risB of serious GI a-5erse reactions, inc)u-in. inf)ammation,
b)ee-in., u)ceration, an- perforation of t/e stomac/ or intestines, 0/ic/ can be fata)4 ,/ese e5ents can occur
an< time -urin. use an- 0it/out 0arnin. s<mptoms4 E)-er)< patients are at .reater risB of serious GI e5ents4
$onitor
Do))o0 c/ronica))< treate- patients for si.ns an- s<mptoms of GI tract u)ceration an- b)ee-in.4 Monitor 1D,s
perio-ica))< -urin. )on.%term t/erap<4 Monitor rena) function in patients 0it/ compromise- Bi-ne< function4
Monitor ;.b in patients 0it/ )o0 ;.b an- /ematocrit )e5e)s4 !erform e<e examinations if patient experiences
5isua) -isturbances4 C)ose)< monitor B! -urin. t/e initiation of treatment an- t/rou./out t/e course of
t/erap<4 Carefu))< monitor patients 0/o ma< be a-5erse)< affecte- b< a)terations in p)ate)et function #e.,
patients 0it/ coa.u)ation -isor-ers or recei5in. anticoa.u)ant t/erap<(4
Pregnanc,
Cate.or< C 4
actation
6n-etermine-4
Elderl,
Increase- risB of a-5erse reactions4
Renal Function
6se is not recommen-e- in patients 0it/ a-5ance- Bi-ne< -isease4 1on.%term
treatment 0it/ *+AIDs ma< resu)t in rena) papi))ar< necrosis an- ot/er rena)
inGur<4
(pecial Ris0 Patients
6se 0it/ caution in patients 0it/ f)ui- retention, /<pertension, or /eart fai)ure4
Anap&,lactoid reactions
Do not a-minister to patients 0it/ aspirin tria-, 0/ic/ occurs t<pica))< in
ast/matic patients 0/o experience r/initis 0it/ or 0it/ nasa) po)<ps, or 0/o
ex/ibit se5ere, potentia))< fata) bronc/ospasm after taBin. aspirin or ot/er
*+AIDs4
Ast&*a
!atients 0it/ ast/ma ma< /a5e aspirin%sensiti5e ast/ma, 0/ic/ ma< be
associate- 0it/ se5ere an- sometimes fata) bronc/ospasm4 Ibuprofen s/ou)- not
be a-ministere- to patients 0it/ t/is t<pe of aspirin%sensiti5it< because of
possib)e cross%reacti5it<4
8,pertension
*e0 /<pertension or 0orsenin. of preexistin. /<pertension, eit/er of 0/ic/ ma<
contribute to increase- risB of CF e5ents, ma< occur4
Platelet function
*+AIDs in/ibit p)ate)et a..re.ation an- /a5e been reporte- to pro)on. b)ee-in.
time4
(0in reactions
+erious an- sometimes fata) sBin a-5erse reactions, inc)u-in. exfo)iati5e
-ermatitis, +te5ens%Ho/nson s<n-rome, an- toxic epi-erma) necro)<sis, ma<
occur4
Overdosage
(,*pto*s
Acute rena) fai)ure, apnea, c<anosis, -ro0siness, epi.astric pain, GI
irritation2b)ee-in., )et/ar.<, metabo)ic aci-osis, nausea, s0eatin., tinnitus,
5omitin.4
Patient Infor*ation
,e)) patient to taBe me-ication soon after mea)s or 0it/ foo-, mi)B, or
antaci-s4
,e)) patient to a5oi- a)co/o) an- me-ications containin. aspirin, suc/ as
co)- reme-ies4
A-5ise patient to -iscontinue -ru. an- imme-iate)< notif< /ea)t/ care
pro5i-er if an< of t/e fo))o0in. occur" persistent or recurrent GI upset or
stomac/ painA sBin ras/ or itc/in.A 5omitin. b)oo-A b)oo-< or b)acB stoo)sA
rapi- 0ei./t .ain or s0e))in.A c/an.es in urine patternsA Goint painA fe5erA
b)ee-in. or unusua) bruisin.A unexp)aine- tire-ness or fati.ueA intestina)
f)u%)iBe s<mptomsA <e))o0in. of t/e sBin or e<esA 5isua) c/an.es4
A-5ise patient to seeB emer.enc< me-ica) assistance if an< of t/e
fo))o0in. occur" s/ortness of breat/ or troub)e breat/in.A c/est painA
0eaBness in one part or on one si-e of bo-<A s)urre- speec/A s0e))in. of
t/e face or t/roat4
Instruct patient not to taBe ',C preparation for more t/an -a<s 0/en
treatin. fe5er an- more t/an 10 -a<s 0/en treatin. pain, an- to notif<
/ea)t/ care pro5i-er if con-ition -oes not impro5e4
A-5ise patient t/at -ru. ma< cause -ro0siness an- to use caution 0/i)e
-ri5in. or performin. ot/er tasBs reIuirin. menta) a)ertness4
C %AR+IO9A(%UAR (:(2E$
C01 %AR+IA% 28ERAP:
C01E O28ER %AR+IA% PREPARA2ION(
C01EB Ot&er cardiac preparations
DDD 6nit A-m4route *otes
C01EB02 %a*p&ora 0415 . '
C01EB0 Indo*etacin
C01EB04 %rataegus gl,cosides
C01EB05 %reatinolfosfate
C01EB06 Fosfocreatine
C01EB0? Fructose -5;"dip&osp&ate
C01EB0@ Ubidecarenone
C01EB10 Adenosine 15 m. !
C01EB11 2iraci<ine
C01EB12 2edisa*il
C01EB1 Acadesine
C01EB15 2ri*eta<idine 40 m. '
C01EB16 Ibuprofen 0 m. !
C01EB1? Ivabradine 10 m. '
C01EB13 Ranola<ine 145 . '
*e0 searc/
G #ENI2O URINAR: (:(2E$ AN+ (E= 8OR$ONE(
G02 O28ER #:NE%OO#I%A(
G02C O28ER #:NE%OO#I%A(
G02CC Antiinfla**ator, products for vaginal ad*inistration
DDD 6nit A-m4route *otes
G02CC01 Ibuprofen
G02CC02 Napro)en
G02CC0 Ben<,da*ine
G02CC04 Fluno)aprofen
*e0 searc/
M $U(%UO"(>EE2A (:(2E$
M01 AN2IINFA$$A2OR: AN+ AN2IR8EU$A2I% PRO+U%2(
M01A AN2IINFA$$A2OR: AN+ AN2IR8EU$A2I% PRO+U%2(5 NON"(2EROI+(
M01AE Propionic acid derivatives
DDD 6nit A-m4route *otes
M01AE01 Ibuprofen 142 . '
M01AE01 Ibuprofen 142 . &
M01AE02 Napro)en 045 . '
M01AE02 Napro)en 045 . &
M01AE0 >etoprofen 0415 . '
M01AE0 >etoprofen 0415 . !
M01AE0 >etoprofen 0415 . &
M01AE04 Fenoprofen 142 . '
M01AE05 Fenbufen 046 . '
M01AE06 Beno)aprofen
M01AE0? (uprofen 044 . '
M01AE03 Pirprofen 043 . '
M01AE0@ Flurbiprofen 042 . '
M01AE0@ Flurbiprofen 042 . &
M01AE10 Indoprofen
M01AE11 2iaprofenic acid 046 . '
M01AE11 2iaprofenic acid 046 . &
M01AE12 O)apro<in 04@ . '
M01AE1 Ibupro)a*
M01AE14 +e)ibuprofen 043 . '
M01AE15 Fluno)aprofen
M01AE16 Al*inoprofen
M01AE1? +e)0etoprofen ?5 m. ' J
M01AE1? +e)0etoprofen ?5 m. !
M01AE51 Ibuprofen5 co*binations
M01AE5 >etoprofen5 co*binations
*e0 searc/
M $U(%UO"(>EE2A (:(2E$
M02 2OPI%A PRO+U%2( FOR 'OIN2 AN+ $U(%UAR PAIN
M02A 2OPI%A PRO+U%2( FOR 'OIN2 AN+ $U(%UAR PAIN
M02AA Antiinfla**ator, preparations5 non"steroids for topical
use
DDD 6nit A-m4route *otes
M02AA01 P&en,lbuta<one
M02AA02 $ofebuta<one
M02AA0 %lofe<one
M02AA04 O),p&enbuta<one
M02AA05 Ben<,da*ine
M02AA06 Etofena*ate
M02AA0? Piro)ica*
M02AA03 Felbinac
M02AA0@ Bufe)a*ac
M02AA10 >etoprofen
M02AA11 Benda<ac
M02AA12 Napro)en
M02AA1 Ibuprofen
M02AA14 Fentia<ac
M02AA15 +iclofenac
M02AA16 Fepra<one
M02AA1? Niflu*ic acid
M02AA13 $eclofena*ic acid
M02AA1@ Flurbiprofen
M02AA21 2ol*etin
M02AA22 (u)ibu<one
M02AA2 Indo*etacin
M02AA24 Nifena<one
M02AA25 Aceclofenac
!acBin.2!resentation
For* Pac0ing4Price P&oto
Fil*"coated caplet
1..*g ) -. ) -.'s
1..*g ) -...'s
7Manufacturer9 Ber)ico Mu)ia Darma